Why the study?
Does nebivolol compared to atenolol improve insulin sensitivity and haemodynamics in hypertensive patients with impaired glucose tolerance?
Does nebivolol compared to atenolol improve insulin sensitivity and haemodynamics in hypertensive patients with impaired glucose tolerance?
In hypertensive patients with impaired glucose tolerance, nebivolol effectively lowers blood pressure without the adverse metabolic effects on insulin sensitivity seen with atenolol.
No takes yet. Share an insight, caveat, or question.
Nebivolol may be preferred over atenolol in hypertensive patients with impaired glucose tolerance; challenges uniform beta-blocker metabolic effects.
Poirier et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: